| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $142,610 ) |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | U01MD019540 | Train and EMPOWER A Community Health workforce to achieve equity and reduce disparities in mental health (TEACH) | 000 | 2 | NIH | 11/8/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15GM116031 | Catalytic Reductive C-H and C-C Silylation with Silyl Acetals | 001 | 3 | NIH | 10/23/2024 | $1,219 |
| | 2025 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM128885 | Mechanisms of host protection during infection via the mitochondrial unfolded protein response | 000 | 6 | NIH | 11/14/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R34AA028730 | Examining Motivations for and Quality of Alcohol and Marijuana Protective Behavior Strategy Use: Improving Prevention of Hazardous Young Adult Substance Use | 001 | 4 | NIH | 10/25/2024 | $142,628 |
| | 2025 | 2023 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R34AA028730 | Examining Motivations for and Quality of Alcohol and Marijuana Protective Behavior Strategy Use: Improving Prevention of Hazardous Young Adult Substance Use | 003 | 4 | NIH | 10/31/2024 | -$18 |
| | 2025 | 2020 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15GM116031 | Catalytic Reductive C-H and C-C Silylation with Silyl Acetals | 000 | 2 | NIH | 10/23/2024 | -$1,219 |
|
| Issue Date FY: 2024 ( Subtotal = $9,538,825 ) (Continued on the next page) |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT ARLINGTON | 701 S. NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R25EB032766 | Enhancing Undergraduate Bioengineering Education through Engaged Service Learning, Clinical Immersion, and Entrepreneurship | 000 | 3 | NIH | 12/22/2023 | $41,600 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01AG086447 | Mechanisms of CD8+ mediated cell non-autonomous arterial aging | 000 | 1 | NIH | 4/3/2024 | $608,811 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R25HL163861 | UTA Summer Undergraduate Research Program to Promote Diversity in Health Related Research | 000 | 3 | NIH | 6/14/2024 | $127,939 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01NS129219 | Multifaceted role of MG53 in alleviating neuromuscular function decline in ALS | 000 | 2 | NIH | 6/12/2024 | $617,807 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R03CA292975 | Impact of Rural Hospital Closures on Cancer Outcomes and Cancer Racial Disparity among Medicare Beneficiaries | 000 | 1 | NIH | 9/19/2024 | $171,163 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM150947 | High spatiotemporal optical imaging to study dynamics of 3D cell motion and behavior in living organisms | 000 | 2 | NIH | 8/9/2024 | $390,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R21HL167171 | Retrospective Single Image Multi-endPoint anaLysis (SIMPL) to define pathophysiologic mechanisms of heart failure with preserved ejection fraction. | 000 | 2 | NIH | 8/24/2024 | $122,220 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | K01MH129991 | Assessing the impacts of Medicaid Home and Community Based Waivers for children with Severe Emotional Disturbance | 000 | 3 | NIH | 4/22/2024 | $169,164 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01DE031872 | Semiconductor Biomaterials to Speed Bone Healing: A Bioengineering-Driven Approach | 001 | 2 | NIH | 6/5/2024 | $36,533 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM142489 | In Vivo Genetic Analysis of Compartmentalized Cell Elimination | 002 | 4 | NIH | 7/16/2024 | $5,714 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM142489 | In Vivo Genetic Analysis of Compartmentalized Cell Elimination | 001 | 4 | NIH | 7/15/2024 | $374,356 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT ARLINGTON | 701 S. NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01DE031872 | Semiconductor Biomaterials to Speed Bone Healing: A Bioengineering-Driven Approach | 000 | 2 | NIH | 2/28/2024 | $411,012 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM142489 | In Vivo Genetic Analysis of Compartmentalized Cell Elimination | 000 | 3 | NIH | 5/2/2024 | $817 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R00AA028537 | Reducing blood pressure in mid-life adult binge drinkers: the role of microvascular function and sympathetic activity | 001 | 5 | NIH | 5/17/2024 | $23,228 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R00AA028537 | Reducing blood pressure in mid-life adult binge drinkers: the role of microvascular function and sympathetic activity | 000 | 5 | NIH | 5/14/2024 | $221,126 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | U01MD019540 | Train and EMPOWER A Community Health workforce to achieve equity and reduce disparities in mental health (TEACH) | 003 | 2 | NIH | 9/25/2024 | $141,006 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | U01MD019540 | Train and EMPOWER A Community Health workforce to achieve equity and reduce disparities in mental health (TEACH) | 001 | 2 | NIH | 6/9/2024 | $702,620 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | U01MD019540 | Train and EMPOWER A Community Health workforce to achieve equity and reduce disparities in mental health (TEACH) | 002 | 2 | NIH | 6/11/2024 | $59,306 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S. Nedderman Dr | Arlington | TX | 76109-0145 | | USA | UR650344 | Maternal Health Research Network (MH-RN) for MSIs--Research Awards | 00 | 2 | HRSA | 8/2/2024 | $449,990 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | F31AI169954 | A nanocoating for continuous disinfection of frequently touched surfaces | 001 | 2 | NIH | 5/15/2024 | $1,280 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT ARLINGTON | 701 S. NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | F31AI169954 | A nanocoating for continuous disinfection of frequently touched surfaces | 000 | 2 | NIH | 11/17/2023 | $39,182 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM155429 | Understanding what regulates a regulator: the molecular basis for homeostatic small RNA-mediated gene regulation | 000 | 1 | NIH | 7/23/2024 | $374,188 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | U01CE003535 | RFA-CE-20-001, Evaluating Practice-based Programs, Policies, and Practices from CDCs Rape Prevention and Education (RPE) Program: Expanding the Evidence to Prevent Sexual Violence - 2020 | 00 | 3 | CDC | 5/31/2024 | $561,999 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15CA294297 | Development of Tailored, Multilevel Cervical Cancer Interventions for Ethnically Diverse Black Women | 000 | 1 | NIH | 8/26/2024 | $477,869 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | K01AG081455 | Spanish Language Older Adult eHealth Learning | 001 | 2 | NIH | 6/26/2024 | $126,873 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15GM116031 | Catalytic Reductive C-H and C-C Silylation with Silyl Acetals | 000 | 3 | NIH | 8/21/2024 | $449,248 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01MD017596 | Complex Systems Approaches to Advance Maternal Health Disparities Research and Prevention: Developing a System Dynamics Simulation Model of Severe Maternal Morbidity among Black Women | 000 | 2 | NIH | 7/31/2024 | $362,166 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R16GM146705 | Using Cognitive Offloading to Mitigate Age-Related Declines in Prospective Memory | 000 | 3 | NIH | 8/7/2024 | $192,500 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01HL158204 | Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease | 002 | 3 | NIH | 6/20/2024 | $41,823 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM128885 | Mechanisms of host protection during infection via the mitochondrial unfolded protein response | 002 | 6 | NIH | 8/23/2024 | $99,352 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R21GM148895 | EnzyDock-based Multistate and Multiscale Tools for Covalent Drug Design | 001 | 2 | NIH | 6/18/2024 | $16,201 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | K01HD106070 | Integrating Evidence-based Approaches to Prevent Child Maltreatment in Kyrgyzstan | 000 | 3 | NIH | 8/9/2024 | $132,034 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01AG075582 | Mapping Trajectories of Alzheimer's Progression via Personalized Brain Anchor-nodes | 001 | 3 | NIH | 6/25/2024 | $54,292 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15GM152973 | Mechanistic characterizations of redox regulations and functions of Arf and Rho families | 000 | 1 | NIH | 5/20/2024 | $26,084 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01HL158204 | Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease | 001 | 3 | NIH | 5/3/2024 | $59,904 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01EB033913 | A Novel Spray-On Sensing Platform Technology that Enables Wearable Visual Monitoring of Physiological Data and Environmental Exposure | 000 | 2 | NIH | 5/21/2024 | $256,876 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01AI148917 | Control of cell wall synthesis and antibiotic tolerance in mycobacteria | 000 | 5 | NIH | 5/28/2024 | $364,032 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R15GM152936 | The role of U1 snRNP proteins in snRNP biogenesis and gene expression regulation | 000 | 1 | NIH | 5/10/2024 | $56,923 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01HL158204 | Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease | 000 | 3 | NIH | 5/2/2024 | $470,519 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01AR081979 | Biomolecule releasing adhesive for cell-mediated labral repair | 000 | 2 | NIH | 6/7/2024 | $406,777 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS AT ARLINGTON | 701 S NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R01AI148917 | Control of cell wall synthesis and antibiotic tolerance in mycobacteria | 001 | 5 | NIH | 5/30/2024 | $32,639 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS AT ARLINGTON | 701 S. NEDDERMAN DR | ARLINGTON | TX | 76019-9800 | TARRANT | USA | R35GM128885 | Mechanisms of host protection during infection via the mitochondrial unfolded protein response | 001 | 6 | NIH | 2/27/2024 | $372,319 |
|
